Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Ti Badri

1PUBLICATIONS
10CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Jan 14, 2022
T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma.

Alexander X Lozano, Aadel A Chaudhuri, Aishwarya Nene

Pageof 1

Frequent Collaborators

1 joint publications

Alexander X Lozano

1 joint publications

Aadel A Chaudhuri

1 joint publications

Aishwarya Nene

1 joint publications

Matthew D Vesely

1 joint publications

Abul Usmani

1 joint publications

Chloé B Steen

1 joint publications

David Y Chen

1 joint publications

Mario Sznol

1 joint publications

Ruth Halaban

1 joint publications

Aaron M Newman

Frequent Collaborators

1 joint publications

Alexander X Lozano

1 joint publications

Aadel A Chaudhuri

1 joint publications

Aishwarya Nene

1 joint publications

Matthew D Vesely

Top Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on : Feb 24, 2023

3.6K
See more related videos

Top Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on : Feb 24, 2023

3.6K
See more related videos